• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

XTL Biopharmaceuticals Ltd

+ Add to Watchlist

XTLB:US

2.1701 USD 0.1399 6.06%

As of 09:44:22 ET on 09/02/2014.

Snapshot for XTL Biopharmaceuticals Ltd (XTLB)

Open: 2.3000 Day's Range: 2.1701 - 2.3000 Volume: 1,100
Previous Close: 2.3100 52wk Range: 1.9300 - 6.2100 1-Yr Rtn: -62.17%

Stock Chart for XTLB

No chart data available.
  • XTLB:US 2.1701
  • 1D
  • 1M
  • 1Y
2.3100
Interactive XTLB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XTLB

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 26.90
Shares Outstanding (M) 11.64
30 Day Average Volume 3,770
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XTLB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XTLB

XTL Biopharmaceuticals, Ltd. is a biopharmaceutical company. The Company offers acquisition and development of pharmaceutical products for the treatment of unmet medical needs, particularly the treatment of multiple myeloma and hepatitis X.

David GrossmanChief Executive OfficerDavid KestenbaumChief Financial Officer
Moshe MittelmanDirector:Medical
More Company Profile & Key Executives for XTLB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil